Royal Society of Chemistry, Nanoscale, 45(11), p. 22054-22069, 2019
DOI: 10.1039/c9nr02866h
Full text: Unavailable
Directly and accurately characterizing the transport of nanoparticles across the blood–brain barrier will greatly advance the delivery of therapies against brain disorders.